文献速递医学人工智能与信息学基础与转化研究

可穿戴动作捕捉套装与机器学习预测弗里德赖希共济失调疾病进展

A wearable motion capture suit and machine learning predict disease progression in Friedreich's ataxia.
PubMed 文献 · Nat Med · 2023-01-19

本研究从9例弗里德赖希共济失调(FA)患者和9名年龄性别匹配对照者的可穿戴传感器中采集全身运动 kinematics,进行8米步行测试和9孔钉板测试,定义数字行为特征。机器学习结合这些特征可纵向预测FA患者未来9个月的SARA和SCAFI评分,精确度分别是用仅SARA和SCAFI评分纵向预测的1.7倍和4倍,并能横断面准确预测FXN基因表达水平。

要点

  • 数字行为特征可纵向预测FA患者未来9个月的个体SARA和SCAFI评分。
  • 预测精确度分别是用仅SARA和SCAFI评分纵向预测的1.7倍和4倍。
  • 数字行为特征能横断面准确预测每例FA患者的FXN基因表达水平。

核心结论

  • 数据衍生的可穿戴生物标志物能追踪个体疾病轨迹,并可能大幅缩短临床试验时长或减小规模,以及实现行为转录组学。

研究设计与样本

  • 从9例FA患者(6女3男)和9名年龄性别匹配对照者采集可穿戴传感器全身运动 kinematics,进行8米步行测试和9孔钉板测试。
  • 使用机器学习结合数字行为特征纵向预测FA患者临床评分,并与SCAFI和SARA两种标准临床评估比较。

主要发现

  • 数字行为特征可纵向预测个人SARA和SCAFI评分至未来9个月。
  • 数字行为特征纵向预测的精确度是用仅SARA评分纵向预测的1.7倍,是用仅SCAFI评分纵向预测的4倍。
  • 数字行为特征能横断面准确预测每例FA患者的FXN基因表达水平,而两种临床量表不能。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Friedreich's ataxia (FA) is caused by a variant of the Frataxin (FXN) gene, leading to its downregulation and progressively impaired cardiac and neurological function. Current gold-standard clinical scales use simplistic behavioral assessments, which require 18- to 24-month-long trials to determine if therapies are beneficial. Here we captured full-body movement kinematics from patients with wearable sensors, enabling us to define digital behavioral features based on the data from nine FA patients (six females and three males) and nine age- and sex-matched controls, who performed the 8-m walk (8-MW) test and 9-hole peg test (9 HPT). We used machine learning to combine these features to longitudinally predict the clinical scores of the FA patients, and compared these with two standard clinical assessments, Spinocerebellar Ataxia Functional Index (SCAFI) and Scale for the Assessment and Rating of Ataxia (SARA). The digital behavioral features enabled longitudinal predictions of personal SARA and SCAFI scores 9 months into the future and were 1.7 and 4 times more precise than longitudinal predictions using only SARA and SCAFI scores, respectively. Unlike the two clinical scales, the digital behavioral features accurately predicted FXN gene expression levels for each FA patient in a cross-sectional manner. Our work demonstrates how data-derived wearable biomarkers can track personal disease trajectories and indicates the potential of such biomarkers for substantially reducing the duration or size of clinical trials testing disease-modifying therapies and for enabling behavioral transcriptomics.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Kadirvelu B, Gavriel C, Nageshwaran S, et al. A wearable motion capture suit and machine learning predict disease progression in Friedreich's ataxia. Nat Med. 2023. PMID: 36658420. doi:10.1038/s41591-022-02159-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。